2 October 2020 (Friday) - Transfusion News Update

The nice people at Transfusion News sent their update today. It was rather COVID-19 focussed, but that is the world of today…

COVID-19 Convalescent Plasma Provides More than Neutralizing Antibodies

Transfusion News Image 1
September 30, 2020
With few drugs to combat SARS-CoV-2 infections and the approval from the U.S. FDA for Emergency Use Authorization of COVID-19 convalescent plasma (CCP), many patients are now receiving CCP. In order to gain a better understanding of the antiviral properties of CCP, researchers profiled 126 plasma samples from eligible convalescent donors using an Fc array assay customized for [Read More]
Platelia SARS-CoV-2 Total Ab assay Now Available
Transfusion News Image 1
In response to demands for a reliable and effective serological test for COVID-19, Bio-Rad now offers the Platelia SARS-CoV-2 Total Ab assay for the detection of total antibodies (IgM, IgA and IgG) to SARS-CoV-2, the virus associated with COVID-19.

This blood-based immunoassay was designed for identifying people who have been exposed to SARS-CoV-2. Providing total antibody detection (IgM, IgA, IgG) in just one test, the assay has been validated on Bio-Rad EVOLIS Instruments and can also be run using manual and automated, high-volume testing protocols. [Click for more]
Less than 2% of U.S. Blood Donations Positive for SARS-CoV-2 Antibodies
September 22, 2020
In order to gain a better understanding of SARS-CoV-2 seroprevalence, the American Red Cross tested all blood donations from June 15, 2020 to August 23, 2020 for anti-SARS-CoV-2 IgG. Of the 953,926 donations collected, 17,336 (1.82%) were positive for SARS-CoV-2 antibodies. Almost 3% (N=4786) of first-time donors were [Read More]
Transfusion News Image 2


No comments:

Post a comment